We partner with pharmaceutical companies and private equity investors to conduct commercial diligence for investments in products, portfolios and healthcare services.
200+ Commercial assessments conducted
75+ M&A transactions supported
30+ Search and evaluation projects completed
Corporate Strategy
Due Diligence
We help leadership teams define and evaluate strategic options across portfolios, therapeutic areas, and growth pathways. Our work supports decisions around R&D prioritization, resource allocation, and long-term strategy by grounding ambition in commercial reality.
We conduct a rigorous assessment of commercial potential, evaluating market opportunity, competitive dynamics, pricing and access considerations, and key risks to help clients make confident, well-informed transaction decisions.
Commercial assessments integrate market landscape analysis, unmet need, patient and prescriber dynamics, competitive positioning, and access considerations. The goal is to quantify opportunity, identify risks, and clarify value drivers that matter most to investors and decision-makers. We have completed over 200 commercial assessments, and can offer our clients a seasoned point-of-view.
Yes. We can help you identify targets by defining strategic criteria, screening potential opportunities, and assessing fit and value across a wide range of assets or companies. Our goal is to help teams focus time and resources on the most attractive opportunities.
We provide clear, decision-ready insights that illuminate trade-offs, test assumptions, and highlight both upside and downside scenarios. This enables leadership teams to move forward with greater clarity, alignment, and confidence, whether pursuing growth, transactions, or portfolio changes.